NMRA

Neumora Therapeutics, Inc. Common StockNASDAQHealthcare

$2.00-4.31%ClosedMarket Cap: $334.2M

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-03-31	Needham	—	Buy	—
2026-03-31	Guggenheim	—	Buy	—
2026-02-17	William Blair	—	Outperform	—
2025-12-01	RBC Capital	—	Outperform	—
2025-11-17	Stifel	—	Hold	—
2025-10-28	Needham	—	Buy	—
2025-10-27	Guggenheim	—	Buy	—
2025-09-16	JP Morgan	—	Underweight	—
2025-07-16	Mizuho	—	Outperform	—
2025-05-13	Needham	—	Buy	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Thu Dec 31	$-1.05	$625.0K	7
Fri Dec 31	$-1.07	$3.5M	6
Sun Dec 31	$-0.89	$71.8M	8
Mon Dec 31	$-0.51	$221.9M	6